Stereoselective opiate antagonist induced hyperalgesia: evidence for a dopaminergic involvement
Gonzalez, J.P.; Littler, M.E.; Sewell, R.D.
Journal of Pharmacy and Pharmacology 34(5): 334-336
1982
ISSN/ISBN: 0022-3573 PMID: 6123576 Document Number: 194915
Document emailed within 1 workday
Related Documents
Pasternak, G.W.; Childers, S.R.; Snyder, S.H. 1980: Naloxazone, a long-acting opiate antagonist: effects on analgesia in intact animals and on opiate receptor binding in vitro Journal of Pharmacology and Experimental Therapeutics 214(3): 455-462Pechnick, R.N.; George, R. 1989: Characterization of the effects of the acute and chronic administration of phencyclidine on body temperature in the rat: lack of evidence for the involvement of opiate receptors Journal of Pharmacology and Experimental Therapeutics 248(3): 900-906
Nicolodi, M.; Volpe, A.R.; Del Bianco, P.L.; Sicuteri, F. 1997: Inheritable and acquired hyperalgesia associated to abnormal opioid receptor set-up seem to act as opiate addiction preventors International Journal of Clinical Pharmacology Research 17(2-3): 85-88
Horn, V.J.; Baum, B.J.; Ambudkar, I.S. 1991: Muscarinic receptor antagonist effects in parotid acini and M1-CHO cells: evidence of G protein involvement Biochemical and Biophysical Research Communications 177(2): 784-789
Niwa, T.; Tokuma, Y.; Nakagawa, K.; Noguchi, H. 1989: Stereoselective oxidation of nilvadipine, a new dihydropyridine calcium antagonist, in rat and dog liver Drug Metabolism and Disposition: the Biological Fate of Chemicals 17(1): 64-68
Noda, Y.; Miyamoto, Y.; Mamiya, T.; Kamei, H.; Furukawa, H.; Nabeshima, T. 1998: Involvement of dopaminergic system in phencyclidine-induced place preference in mice pretreated with phencyclidine repeatedly Journal of Pharmacology and Experimental Therapeutics 286(1): 44-51
Urban, M.O.; Smith, D.J.; Gebhart, G.F. 1996: Involvement of spinal cholecystokininB receptors in mediating neurotensin hyperalgesia from the medullary nucleus raphe magnus in the rat Journal of Pharmacology and Experimental Therapeutics 278(1): 90-96
Loutzenhiser, R.; Epstein, M.; Horton, C.; Sonke, P. 1985: Reversal by the calcium antagonist nisoldipine of norepinephrine-induced reduction of GFR: evidence for preferential antagonism of preglomerular vasoconstriction Journal of Pharmacology and Experimental Therapeutics 232(2): 382-387
Paul, L.; Fraifeld, V.; Kaplanski, J. 1999: Evidence supporting involvement of leukotrienes in LPS-induced hypothermia in mice American Journal of Physiology 276(1): R52-R58
Fjellner, B.; Hägermark, O. 1984: The influence of the opiate antagonist naloxone on experimental pruritus Acta Dermato-Venereologica 64(1): 73-75
Michel, M.E.; Bolger, G.; Weissman, B.A. 1985: Binding of a new opiate antagonist, nalmefene, to rat brain membranes Methods and Findings in Experimental and Clinical Pharmacology 7(4): 175-177
Siegel, R.A.; Révész, L. 1989: Effects of the novel opiate antagonist, SDZ 210-096, on luteinizing hormone secretion in the rat Journal of Pharmacology and Experimental Therapeutics 249(1): 264-270
Hedge, S.S.; Moy, T.M.; Perry, M.R.; Loeb, M.; Eglen, R.M. 1994: Evidence for the involvement of 5-hydroxytryptamine 4 receptors in 5-hydroxytryptophan-induced diarrhea in mice Journal of Pharmacology and Experimental Therapeutics 271(2): 741-747
Vallera, D.A.; Gamble, C.E.; Schmidtke, J.R. 1980: Lipopolysaccharide-induced immunomodulation of the generation cell-mediated cytotoxicity. II. Evidence for the involvement of a regulatory B lymphocyte Journal of Immunology 124(2): 641-649
Kaye, A.D.; Chung, K.S.; Vadivelu, N.; Cantemir, C.; Urman, R.D.; Manchikanti, L. 2014: Opioid induced hyperalgesia altered with propofol infusion Pain Physician 17(2): E225-E228
Müller, H.; Marck, P.; Gips, H.; Börner, U.; Otto, O.; Adams, H.A.; Hempelmann, G. 1987: Effect of the calcium antagonist nimodipine on hemodynamics, gas exchange and endocrine parameters in opiate anesthesia Der Anaesthesist 36(10): 561-569
Andrews, B.T.; McIntosh, T.K.; Gonzales, M.F.; Weinstein, P.R.; Faden, A.I. 1988: Levels of endogenous opioids and effects of an opiate antagonist during regional cerebral ischemia in rats Journal of Pharmacology and Experimental Therapeutics 247(3): 1248-1254
Wood, P.L.; Stotland, M.; Richard, J.W.; Rackham, A. 1980: Actions of mu, kappa, sigma, delta and agonist/antagonist opiates on striatal dopaminergic function Journal of Pharmacology and Experimental Therapeutics 215(3): 697-703
Bujalska, M.; Winecka, R.; Gumułka, S.ła.W. 2008: Effect of selol on the opioids activity in streptozotocin induced hyperalgesia Acta Poloniae Pharmaceutica 65(6): 691-696
Sørensen, J.; Sjøgren, P. 2011: The clinical relevance of opioid-induced hyperalgesia remains unresolved Ugeskrift for Laeger 173(13): 965-968